Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder – Possible Role for Methoxyindole Pathway-Reference-Cited by-同舟云学术

Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder – Possible Role for Methoxyindole Pathway

Published:2013-07-17 Issue:7 Volume:8 Page:e68283
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Zhu Hongjie,Bogdanov Mikhail B.,Boyle Stephen H.,Matson Wayne,Sharma Swati,Matson Samantha,Churchill Erik,Fiehn Oliver,Rush John A.,Krishnan Ranga R.,Pickering Eve,Delnomdedieu Marielle,Kaddurah-Daouk Rima,Network Pharmacometabolomics Research

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference58 articles.

1. Selective serotonin reuptake inhibitors reduce the spontaneous activity of dopaminergic neurons in the ventral tegmental area;M Di Mascio;Brain Res Bull,1998

2. Plasma serotonin level after 1 day of fluoxetine treatment: a biological predictor for antidepressant response?;JC Alvarez;Psychopharmacology (Berl),1999

3. Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area;E Dremencov;J Psychiatry Neurosci,2009

4. Sertraline, a selective serotonin reuptake inhibitor modulates extracellular noradrenaline in the rat frontal cortex;DN Thomas;J Psychopharmacol,1998

5. Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex;FP Bymaster;Psychopharmacology (Berl),2002

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheral serotonin levels as a predictor of antidepressant treatment response: A systematic review;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-07

2. Metabolomics in Depression: What We Learn from Preclinical and Clinical Evidences;Molecular Neurobiology;2024-06-19

3. Characterization of “microbiome-metabolome-immunity” in depressed rats with divergent responses to Paroxetine;Journal of Affective Disorders;2024-05

4. Pharmacokinetics in Pharmacometabolomics: Towards Personalized Medication;Pharmaceuticals;2023-11-07

5. Selection of the optimal dose of sertraline for depression: A dose-response meta-analysis of randomized controlled trials;Psychiatry Research;2023-09